Ronald H. Laessig

2.9k total citations · 1 hit paper
87 papers, 2.2k citations indexed

About

Ronald H. Laessig is a scholar working on Physiology, Statistics, Probability and Uncertainty and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ronald H. Laessig has authored 87 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Physiology, 17 papers in Statistics, Probability and Uncertainty and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ronald H. Laessig's work include Clinical Laboratory Practices and Quality Control (30 papers), Cystic Fibrosis Research Advances (11 papers) and Neonatal Respiratory Health Research (10 papers). Ronald H. Laessig is often cited by papers focused on Clinical Laboratory Practices and Quality Control (30 papers), Cystic Fibrosis Research Advances (11 papers) and Neonatal Respiratory Health Research (10 papers). Ronald H. Laessig collaborates with scholars based in United States. Ronald H. Laessig's co-authors include Gary Hoffman, Sharon S. Ehrmeyer, Philip M. Farrell, Michael J. Rock, Michael R. Kosorok, Mark Splaingard, Anita Laxova, David J. Hassemer, Lan Zeng and Hui-Chuan Lai and has published in prestigious journals such as Analytical Chemistry, PEDIATRICS and Journal of Allergy and Clinical Immunology.

In The Last Decade

Ronald H. Laessig

83 papers receiving 2.0k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth

2001 646 citations Philip M. Farrell, Michael R. Kosorok et al. PEDIATRICS profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronald H. Laessig United States	20	936	338	311	264	248	87	2.2k
Kevin W Southern United Kingdom	30	3.5k 3.8×	343 1.0×	377 1.2×	344 1.3×	72 0.3×	133	4.4k
Iain M. Murray‐Lyon United Kingdom	31	181 0.2×	234 0.7×	363 1.2×	219 0.8×	88 0.4×	96	3.2k
Clement L. Ren United States	29	2.3k 2.4×	296 0.9×	176 0.6×	258 1.0×	25 0.1×	112	3.0k
Stephen Kirk United Kingdom	25	204 0.2×	339 1.0×	65 0.2×	245 0.9×	57 0.2×	70	2.1k
Robert T. Hall United States	34	1.2k 1.3×	152 0.4×	945 3.0×	126 0.5×	122 0.5×	133	3.6k
Samuel M. Lesko United States	28	521 0.6×	542 1.6×	393 1.3×	215 0.8×	13 0.1×	46	2.7k
Leo A. Heitlinger United States	24	153 0.2×	193 0.6×	174 0.6×	98 0.4×	37 0.1×	59	1.8k
M G Coulthard Australia	26	394 0.4×	94 0.3×	407 1.3×	448 1.7×	27 0.1×	81	2.0k
Joseph Mattana United States	24	338 0.4×	126 0.4×	82 0.3×	234 0.9×	55 0.2×	111	1.8k
Naveed Ahmad United States	29	297 0.3×	86 0.3×	220 0.7×	286 1.1×	69 0.3×	91	2.4k

Countries citing papers authored by Ronald H. Laessig

Since Specialization

Citations

This map shows the geographic impact of Ronald H. Laessig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald H. Laessig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald H. Laessig more than expected).

Fields of papers citing papers by Ronald H. Laessig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald H. Laessig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald H. Laessig. The network helps show where Ronald H. Laessig may publish in the future.

Co-authorship network of co-authors of Ronald H. Laessig

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald H. Laessig. A scholar is included among the top collaborators of Ronald H. Laessig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald H. Laessig. Ronald H. Laessig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Routes, John M., William J. Grossman, James Verbsky, et al.. (2009). Update of Statewide Newborn Screening Program for Severe Combined Immunodeficiency (SCID) by T-Cell Receptor Excision Circles (TRECs). Journal of Allergy and Clinical Immunology. 123(2). S68–S68. 1 indexed citations

Ehrmeyer, Sharon S. & Ronald H. Laessig. (2006). Regulatory compliance vs. NEXUS quality for laboratory tests. Accreditation and Quality Assurance. 11(6). 265–268. 1 indexed citations

Farrell, Philip M., HuiChuan J. Lai, Zhanhai Li, et al.. (2005). Evidence on Improved Outcomes with Early Diagnosis of Cystic Fibrosis Through Neonatal Screening: Enough is Enough!. The Journal of Pediatrics. 147(3). S30–S36. 127 indexed citations

Rosenberg, Marjorie A., et al.. (2003). Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program. The Journal of Pediatrics. 142(6). 617–623. 40 indexed citations

Farrell, Philip M., Michael R. Kosorok, Michael J. Rock, et al.. (2001). Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth. PEDIATRICS. 107(1). 1–13. 646 indexed citations breakdown →

Ehrmeyer, Sharon S. & Ronald H. Laessig. (1999). The American (USA) perspective six years after implementation of CLIA'88 (Federal) regulations. Accreditation and Quality Assurance. 4(3). 93–98. 2 indexed citations

Allen, David B., et al.. (1997). Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. The Journal of Pediatrics. 130(1). 128–133. 119 indexed citations

Gregg, Ronald G., Philip M. Farrell, Rebecca E. Koscik, et al.. (1997). Newborn Screening for Cystic Fibrosis in Wisconsin: Comparison of Biochemical and Molecular Methods. PEDIATRICS. 99(6). 819–824. 104 indexed citations

Ehrmeyer, Sharon S. & Ronald H. Laessig. (1995). Regulatory requirements (CLIA '88, JCAHO, CAP) for decentralized testing.. PubMed. 104(4 Suppl 1). S40–9. 25 indexed citations

10.

Laessig, Ronald H., et al.. (1992). Limitations of Proficiency Testing Under CLIA '67. Clinical Chemistry. 38(7). 1237–1244. 7 indexed citations

11.

Ehrmeyer, Sharon S., et al.. (1992). Review of Actual Proficiency-Testing Performance Under CLIA '67 (March 14, 1990) Rules: Perspective from the First Year's Data. Clinical Chemistry. 38(7). 1254–1259. 2 indexed citations

12.

Laessig, Ronald H., et al.. (1992). Intralaboratory Performance Requirements Necessary to Pass Proficiency Testing: CAP-1990 vs CLIA-1967 (March 14, 1990) Formats Compared. Clinical Chemistry. 38(6). 895–903. 5 indexed citations

13.

Hill, Barbara M., Ronald H. Laessig, David D. Koch, & David J. Hassemer. (1992). Comparison of Plastic vs. Glass Evacuated Serum-Separator (SSTTM) Blood-Drawing Tubes for Common Clinical Chemistry Determinations. Clinical Chemistry. 38(8). 1474–1478. 26 indexed citations

14.

Farrell, Philip M., Elaine H. Mischler, Norman Fost, et al.. (1991). Current issues in neonatal screening for cystic fibrosis and implications of the CF gene discovery. Pediatric Pulmonology. 11(S7). 11–18. 22 indexed citations

15.

Hassemer, David J., Ronald H. Laessig, Gary Hoffman, & Philip M. Farrell. (1991). Laboratory quality control issues related to screening newborns for cystic fibrosis using immunoreactive trypsin. Pediatric Pulmonology. 11(S7). 76–83. 9 indexed citations

16.

Ehrmeyer, Sharon S., et al.. (1990). 1990 Medicare/CLIA final rules for proficiency testing: minimum intralaboratory performance characteristics (CV and bias) needed to pass. Clinical Chemistry. 36(10). 1736–1740. 46 indexed citations

17.

Laessig, Ronald H., et al.. (1974). Computers in Clinical Chemistry. Analytical Chemistry. 46(4). 398A–417A. 1 indexed citations

18.

Laessig, Ronald H., et al.. (1972). Determination of SMA—Mark X1,2 Set Points for Bilirubin by Standard Addition Technique. Clinical Chemistry. 18(1). 48–51. 4 indexed citations

19.

Laessig, Ronald H., et al.. (1970). Involvement of Alcohol in Fatalities of Wisconsin Drivers. Public Health Reports (1896-1970). 85(6). 535–535. 3 indexed citations

20.

Laessig, Ronald H., et al.. (1967). Evaluation of Cholesterol Determinations among Clinical Laboratories in Wisconsin. Public Health Reports (1896-1970). 82(11). 957–957. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact